Olopatadine Eye Drops Suppliers & Bulk Manufacturers
Available Forms: Drop
Available Strengths: 0.1% w/v, 0.2%, 0.7%
Reference Brands: Patanol (USA), Opatanol (EU)
Category:
Allergy Medication
Olopatadine Eye Drops is a medicine that is used for the treatment of Symptoms Of Allergic Pink Eye and other conditions.
Olopatadine Eye Drops contains Olopatadine Hcl as an active ingredient.
Olopatadine Eye Drops works by blocking histamine in the body.
Olopatadine Eye Drops is available in Drop
and strengths such as 0.1% w/v, 0.2%, 0.7%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Olopatadine Eye Drops is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Olopatadine Eye Drops can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Olopatadine Eye Drops is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · Symptoms Of Allergic Pink Eye
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing